ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pentazocine Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14E9858
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Pentazocine Market Insights Forecast to 2028
BUY CHAPTERS

Global Pentazocine Market Insights, Forecast to 2030

Code: QYRE-Auto-14E9858
Report
December 2024
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
Pfizer Inc
Merck KGaA
Lupin Pharmaceuticals

Pentazocine Market

Pentazocine, sold under the brand name Talwin among others, is a painkiller used to treat moderate to severe pain. It is believed to work by activating (agonizing) κ-opioid receptors (KOR) and blocking (antagonizing) μ-opioid receptors (MOR). As such it is called an opioid as it delivers its effects on pain by interacting with the opioid receptors. It shares many of the side effects of other opioids like constipation, nausea, itching, drowsiness and a reduced effort to breathe, but unlike most other opioids it fairly frequently causes hallucinations, nightmares and delusions. It is also, unlike most other opioids, subject to a ceiling effect, which is when at a certain dose (which differs from person-to-person) no more pain relief, or side effects, is obtained by increasing the dose any further.
The global Pentazocine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pentazocine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pentazocine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Pentazocine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Pentazocine include Teva, pfizer, Merck KGaA and LUPIN PHARMACEUTICALS, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Pentazocine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pentazocine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pentazocine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pentazocine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pentazocine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pentazocine sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pentazocine Market Report

Report Metric Details
Report Name Pentazocine Market
Segment by Type
Segment by Application
  • Adults
  • Children
  • Elderly
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck KGaA, LUPIN PHARMACEUTICALS
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Pentazocine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Pentazocine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pentazocine sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pentazocine Market report?

Ans: The main players in the Pentazocine Market are Merck KGaA, LUPIN PHARMACEUTICALS

What are the Application segmentation covered in the Pentazocine Market report?

Ans: The Applications covered in the Pentazocine Market report are Adults, Children, Elderly

What are the Type segmentation covered in the Pentazocine Market report?

Ans: The Types covered in the Pentazocine Market report are Injections, Tablets

Recommended Reports

Pain Management Drugs

Analgesics & Opioids

Chronic Pain Treatments

1 Study Coverage
1.1 Pentazocine Product Introduction
1.2 Market by Type
1.2.1 Global Pentazocine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Injections
1.2.3 Tablets
1.3 Market by Application
1.3.1 Global Pentazocine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Children
1.3.4 Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pentazocine Sales Estimates and Forecasts 2019-2030
2.2 Global Pentazocine Revenue by Region
2.2.1 Global Pentazocine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Pentazocine Revenue by Region (2019-2024)
2.2.3 Global Pentazocine Revenue by Region (2025-2030)
2.2.4 Global Pentazocine Revenue Market Share by Region (2019-2030)
2.3 Global Pentazocine Sales Estimates and Forecasts 2019-2030
2.4 Global Pentazocine Sales by Region
2.4.1 Global Pentazocine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Pentazocine Sales by Region (2019-2024)
2.4.3 Global Pentazocine Sales by Region (2025-2030)
2.4.4 Global Pentazocine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pentazocine Sales by Manufacturers
3.1.1 Global Pentazocine Sales by Manufacturers (2019-2024)
3.1.2 Global Pentazocine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pentazocine in 2023
3.2 Global Pentazocine Revenue by Manufacturers
3.2.1 Global Pentazocine Revenue by Manufacturers (2019-2024)
3.2.2 Global Pentazocine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pentazocine Revenue in 2023
3.3 Global Key Players of Pentazocine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Pentazocine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pentazocine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pentazocine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pentazocine, Product Offered and Application
3.8 Global Key Manufacturers of Pentazocine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pentazocine Sales by Type
4.1.1 Global Pentazocine Historical Sales by Type (2019-2024)
4.1.2 Global Pentazocine Forecasted Sales by Type (2025-2030)
4.1.3 Global Pentazocine Sales Market Share by Type (2019-2030)
4.2 Global Pentazocine Revenue by Type
4.2.1 Global Pentazocine Historical Revenue by Type (2019-2024)
4.2.2 Global Pentazocine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Pentazocine Revenue Market Share by Type (2019-2030)
4.3 Global Pentazocine Price by Type
4.3.1 Global Pentazocine Price by Type (2019-2024)
4.3.2 Global Pentazocine Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Pentazocine Sales by Application
5.1.1 Global Pentazocine Historical Sales by Application (2019-2024)
5.1.2 Global Pentazocine Forecasted Sales by Application (2025-2030)
5.1.3 Global Pentazocine Sales Market Share by Application (2019-2030)
5.2 Global Pentazocine Revenue by Application
5.2.1 Global Pentazocine Historical Revenue by Application (2019-2024)
5.2.2 Global Pentazocine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Pentazocine Revenue Market Share by Application (2019-2030)
5.3 Global Pentazocine Price by Application
5.3.1 Global Pentazocine Price by Application (2019-2024)
5.3.2 Global Pentazocine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Pentazocine Market Size by Type
6.1.1 US & Canada Pentazocine Sales by Type (2019-2030)
6.1.2 US & Canada Pentazocine Revenue by Type (2019-2030)
6.2 US & Canada Pentazocine Market Size by Application
6.2.1 US & Canada Pentazocine Sales by Application (2019-2030)
6.2.2 US & Canada Pentazocine Revenue by Application (2019-2030)
6.3 US & Canada Pentazocine Market Size by Country
6.3.1 US & Canada Pentazocine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Pentazocine Sales by Country (2019-2030)
6.3.3 US & Canada Pentazocine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pentazocine Market Size by Type
7.1.1 Europe Pentazocine Sales by Type (2019-2030)
7.1.2 Europe Pentazocine Revenue by Type (2019-2030)
7.2 Europe Pentazocine Market Size by Application
7.2.1 Europe Pentazocine Sales by Application (2019-2030)
7.2.2 Europe Pentazocine Revenue by Application (2019-2030)
7.3 Europe Pentazocine Market Size by Country
7.3.1 Europe Pentazocine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Pentazocine Sales by Country (2019-2030)
7.3.3 Europe Pentazocine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pentazocine Market Size
8.1.1 China Pentazocine Sales (2019-2030)
8.1.2 China Pentazocine Revenue (2019-2030)
8.2 China Pentazocine Market Size by Application
8.2.1 China Pentazocine Sales by Application (2019-2030)
8.2.2 China Pentazocine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pentazocine Market Size by Type
9.1.1 Asia Pentazocine Sales by Type (2019-2030)
9.1.2 Asia Pentazocine Revenue by Type (2019-2030)
9.2 Asia Pentazocine Market Size by Application
9.2.1 Asia Pentazocine Sales by Application (2019-2030)
9.2.2 Asia Pentazocine Revenue by Application (2019-2030)
9.3 Asia Pentazocine Sales by Region
9.3.1 Asia Pentazocine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Pentazocine Revenue by Region (2019-2030)
9.3.3 Asia Pentazocine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pentazocine Market Size by Type
10.1.1 Middle East, Africa and Latin America Pentazocine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Pentazocine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Pentazocine Market Size by Application
10.2.1 Middle East, Africa and Latin America Pentazocine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Pentazocine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Pentazocine Sales by Country
10.3.1 Middle East, Africa and Latin America Pentazocine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Pentazocine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Pentazocine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Overview
11.1.3 Teva Pentazocine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Teva Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Recent Developments
11.2 pfizer
11.2.1 pfizer Company Information
11.2.2 pfizer Overview
11.2.3 pfizer Pentazocine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 pfizer Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 pfizer Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Overview
11.3.3 Merck KGaA Pentazocine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck KGaA Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck KGaA Recent Developments
11.4 LUPIN PHARMACEUTICALS
11.4.1 LUPIN PHARMACEUTICALS Company Information
11.4.2 LUPIN PHARMACEUTICALS Overview
11.4.3 LUPIN PHARMACEUTICALS Pentazocine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 LUPIN PHARMACEUTICALS Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LUPIN PHARMACEUTICALS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pentazocine Industry Chain Analysis
12.2 Pentazocine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pentazocine Production Mode & Process
12.4 Pentazocine Sales and Marketing
12.4.1 Pentazocine Sales Channels
12.4.2 Pentazocine Distributors
12.5 Pentazocine Customers
13 Market Dynamics
13.1 Pentazocine Industry Trends
13.2 Pentazocine Market Drivers
13.3 Pentazocine Market Challenges
13.4 Pentazocine Market Restraints
14 Key Findings in The Global Pentazocine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
TEVA
Pfizer Inc
Merck KGaA
Lupin Pharmaceuticals
List of Tables
    Table 1. Global Pentazocine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Injections
    Table 3. Major Manufacturers of Tablets
    Table 4. Global Pentazocine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Pentazocine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Pentazocine Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Pentazocine Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Pentazocine Revenue Market Share by Region (2019-2024)
    Table 9. Global Pentazocine Revenue Market Share by Region (2025-2030)
    Table 10. Global Pentazocine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Pentazocine Sales by Region (2019-2024) & (K Units)
    Table 12. Global Pentazocine Sales by Region (2025-2030) & (K Units)
    Table 13. Global Pentazocine Sales Market Share by Region (2019-2024)
    Table 14. Global Pentazocine Sales Market Share by Region (2025-2030)
    Table 15. Global Pentazocine Sales by Manufacturers (2019-2024) & (K Units)
    Table 16. Global Pentazocine Sales Share by Manufacturers (2019-2024)
    Table 17. Global Pentazocine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Pentazocine Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Pentazocine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Pentazocine Price by Manufacturers 2019-2024 (USD/Unit)
    Table 21. Global Pentazocine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Pentazocine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pentazocine as of 2023)
    Table 23. Global Key Manufacturers of Pentazocine, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Pentazocine, Product Offered and Application
    Table 25. Global Key Manufacturers of Pentazocine, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pentazocine Sales by Type (2019-2024) & (K Units)
    Table 28. Global Pentazocine Sales by Type (2025-2030) & (K Units)
    Table 29. Global Pentazocine Sales Share by Type (2019-2024)
    Table 30. Global Pentazocine Sales Share by Type (2025-2030)
    Table 31. Global Pentazocine Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Pentazocine Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Pentazocine Revenue Share by Type (2019-2024)
    Table 34. Global Pentazocine Revenue Share by Type (2025-2030)
    Table 35. Pentazocine Price by Type (2019-2024) & (USD/Unit)
    Table 36. Global Pentazocine Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 37. Global Pentazocine Sales by Application (2019-2024) & (K Units)
    Table 38. Global Pentazocine Sales by Application (2025-2030) & (K Units)
    Table 39. Global Pentazocine Sales Share by Application (2019-2024)
    Table 40. Global Pentazocine Sales Share by Application (2025-2030)
    Table 41. Global Pentazocine Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Pentazocine Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Pentazocine Revenue Share by Application (2019-2024)
    Table 44. Global Pentazocine Revenue Share by Application (2025-2030)
    Table 45. Pentazocine Price by Application (2019-2024) & (USD/Unit)
    Table 46. Global Pentazocine Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 47. US & Canada Pentazocine Sales by Type (2019-2024) & (K Units)
    Table 48. US & Canada Pentazocine Sales by Type (2025-2030) & (K Units)
    Table 49. US & Canada Pentazocine Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Pentazocine Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Pentazocine Sales by Application (2019-2024) & (K Units)
    Table 52. US & Canada Pentazocine Sales by Application (2025-2030) & (K Units)
    Table 53. US & Canada Pentazocine Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Pentazocine Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Pentazocine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Pentazocine Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Pentazocine Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Pentazocine Sales by Country (2019-2024) & (K Units)
    Table 59. US & Canada Pentazocine Sales by Country (2025-2030) & (K Units)
    Table 60. Europe Pentazocine Sales by Type (2019-2024) & (K Units)
    Table 61. Europe Pentazocine Sales by Type (2025-2030) & (K Units)
    Table 62. Europe Pentazocine Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Pentazocine Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Pentazocine Sales by Application (2019-2024) & (K Units)
    Table 65. Europe Pentazocine Sales by Application (2025-2030) & (K Units)
    Table 66. Europe Pentazocine Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Pentazocine Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Pentazocine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Pentazocine Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Pentazocine Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Pentazocine Sales by Country (2019-2024) & (K Units)
    Table 72. Europe Pentazocine Sales by Country (2025-2030) & (K Units)
    Table 73. China Pentazocine Sales by Type (2019-2024) & (K Units)
    Table 74. China Pentazocine Sales by Type (2025-2030) & (K Units)
    Table 75. China Pentazocine Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Pentazocine Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Pentazocine Sales by Application (2019-2024) & (K Units)
    Table 78. China Pentazocine Sales by Application (2025-2030) & (K Units)
    Table 79. China Pentazocine Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Pentazocine Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Pentazocine Sales by Type (2019-2024) & (K Units)
    Table 82. Asia Pentazocine Sales by Type (2025-2030) & (K Units)
    Table 83. Asia Pentazocine Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Pentazocine Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Pentazocine Sales by Application (2019-2024) & (K Units)
    Table 86. Asia Pentazocine Sales by Application (2025-2030) & (K Units)
    Table 87. Asia Pentazocine Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Pentazocine Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Pentazocine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Pentazocine Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Pentazocine Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Pentazocine Sales by Region (2019-2024) & (K Units)
    Table 93. Asia Pentazocine Sales by Region (2025-2030) & (K Units)
    Table 94. Middle East, Africa and Latin America Pentazocine Sales by Type (2019-2024) & (K Units)
    Table 95. Middle East, Africa and Latin America Pentazocine Sales by Type (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America Pentazocine Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Pentazocine Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Pentazocine Sales by Application (2019-2024) & (K Units)
    Table 99. Middle East, Africa and Latin America Pentazocine Sales by Application (2025-2030) & (K Units)
    Table 100. Middle East, Africa and Latin America Pentazocine Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Pentazocine Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Pentazocine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Pentazocine Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Pentazocine Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Pentazocine Sales by Country (2019-2024) & (K Units)
    Table 106. Middle East, Africa and Latin America Pentazocine Sales by Country (2025-2030) & (K Units)
    Table 107. Teva Company Information
    Table 108. Teva Description and Major Businesses
    Table 109. Teva Pentazocine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Teva Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Teva Recent Developments
    Table 112. pfizer Company Information
    Table 113. pfizer Description and Major Businesses
    Table 114. pfizer Pentazocine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. pfizer Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. pfizer Recent Developments
    Table 117. Merck KGaA Company Information
    Table 118. Merck KGaA Description and Major Businesses
    Table 119. Merck KGaA Pentazocine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Merck KGaA Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Merck KGaA Recent Developments
    Table 122. LUPIN PHARMACEUTICALS Company Information
    Table 123. LUPIN PHARMACEUTICALS Description and Major Businesses
    Table 124. LUPIN PHARMACEUTICALS Pentazocine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 125. LUPIN PHARMACEUTICALS Pentazocine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. LUPIN PHARMACEUTICALS Recent Developments
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Pentazocine Distributors List
    Table 130. Pentazocine Customers List
    Table 131. Pentazocine Market Trends
    Table 132. Pentazocine Market Drivers
    Table 133. Pentazocine Market Challenges
    Table 134. Pentazocine Market Restraints
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pentazocine Product Picture
    Figure 2. Global Pentazocine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pentazocine Market Share by Type in 2023 & 2030
    Figure 4. Injections Product Picture
    Figure 5. Tablets Product Picture
    Figure 6. Global Pentazocine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Pentazocine Market Share by Application in 2023 & 2030
    Figure 8. Adults
    Figure 9. Children
    Figure 10. Elderly
    Figure 11. Pentazocine Report Years Considered
    Figure 12. Global Pentazocine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Pentazocine Revenue 2019-2030 (US$ Million)
    Figure 14. Global Pentazocine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Pentazocine Revenue Market Share by Region (2019-2030)
    Figure 16. Global Pentazocine Sales 2019-2030 ((K Units)
    Figure 17. Global Pentazocine Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Pentazocine Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Pentazocine Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Pentazocine Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Pentazocine Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Pentazocine Sales YoY (2019-2030) & (K Units)
    Figure 23. China Pentazocine Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Pentazocine Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Pentazocine Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Pentazocine Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Pentazocine Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Pentazocine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Pentazocine in the World: Market Share by Pentazocine Revenue in 2023
    Figure 30. Global Pentazocine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Pentazocine Sales Market Share by Type (2019-2030)
    Figure 32. Global Pentazocine Revenue Market Share by Type (2019-2030)
    Figure 33. Global Pentazocine Sales Market Share by Application (2019-2030)
    Figure 34. Global Pentazocine Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Pentazocine Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Pentazocine Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Pentazocine Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Pentazocine Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Pentazocine Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Pentazocine Sales Share by Country (2019-2030)
    Figure 41. U.S. Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Pentazocine Sales Market Share by Type (2019-2030)
    Figure 44. Europe Pentazocine Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Pentazocine Sales Market Share by Application (2019-2030)
    Figure 46. Europe Pentazocine Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Pentazocine Revenue Share by Country (2019-2030)
    Figure 48. Europe Pentazocine Sales Share by Country (2019-2030)
    Figure 49. Germany Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 50. France Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 54. China Pentazocine Sales Market Share by Type (2019-2030)
    Figure 55. China Pentazocine Revenue Market Share by Type (2019-2030)
    Figure 56. China Pentazocine Sales Market Share by Application (2019-2030)
    Figure 57. China Pentazocine Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Pentazocine Sales Market Share by Type (2019-2030)
    Figure 59. Asia Pentazocine Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Pentazocine Sales Market Share by Application (2019-2030)
    Figure 61. Asia Pentazocine Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Pentazocine Revenue Share by Region (2019-2030)
    Figure 63. Asia Pentazocine Sales Share by Region (2019-2030)
    Figure 64. Japan Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 68. India Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Pentazocine Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Pentazocine Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Pentazocine Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Pentazocine Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Pentazocine Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Pentazocine Sales Share by Country (2019-2030)
    Figure 75. Brazil Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Pentazocine Revenue (2019-2030) & (US$ Million)
    Figure 80. Pentazocine Value Chain
    Figure 81. Pentazocine Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Dezocine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Zaleplon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Codeine Painkillers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nitazoxanide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Zaleplon API Market Research Report 2025
Furazolidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 Chloro 2 Pentanone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Codeine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tylosin and Derivatives Market Research Report 2024
Acetazolamide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ketorolac Market Research Report 2024
Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Desloratadine Oral Solution Market Research Report 2025
Codeine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ciclopirox Olamine Market Research Report 2024
Global Alinia nitazoxanide Market Research Report 2025
Cyclizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rilonacept Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Trimetazidine Dihydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pentakis Dimethylamino Tantalum V Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions